Advertisement

Archive

2011: 105/5(May) pp. 743-932

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245
Topic:

Theme Issue
Intravital imaging of inflammation


28 articles
1.
Peri-operative management of antiplatelet therapy in patients with coronary artery disease
Joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC)

See also Editorial by Peter, Myles

W. Korte (1), M. Cattaneo (2), P.-G. Chassot (3), S. Eichinger (4), C. von Heymann (5), N. Hofmann (6), H. Rickli (7), M. Spannagl (8), B. Ziegler (9), F. Verheugt (10), K. Huber (11)

(1) Center for Laboratory Medicine, Kantonsspital St. Gallen, Switzerland; (2) Medicina 3, Ospedale San Paolo, Department of Medicine, Surgery and Dentistry, Università degli Studi di Milano, Milan, Italy; (3) Departement of Anesthesiology, University Hospital Lausanne, Switzerland; (4) Department of Medicine I, Division of Hematology, Medical University of Vienna, Austria; (5) Department of Anesthesiology and Intensive Care, Charité-Universitätsmedizin Berlin, Germany; (6) Department of Anesthesiology, Diakonissen-Krankenhaus Salzburg, Austria; (7) Division of Cardiology, Kantonsspital St. Gallen, Switzerland; (8) Division of Haemostaseology, University of Munich, Germany; (9) Department of Anesthesiology, Landeskliniken Salzburg, Austria; (10) Department of Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands; (11) 3rd Department of Medicine, Wilhelminenhospital, Vienna, Austria

Thromb Haemost 2011 105 5: 743-749

https://doi.org/10.1160/TH10-04-0217

[Summary] [Free PDF] [Export citation]
2.

Editorial on Korte et al.

K. Peter (1, 2), P. S. Myles (3, 2)

(1) Baker IDI Heart and Diabetes Institute, Melbourne, Australia; (2) Monash University, Melbourne, Australia; (3) Department of Anaesthesia and Perioperative Medicine, Alfred Hospital, Melbourne, Australia

Thromb Haemost 2011 105 5: 750-751

https://doi.org/10.1160/TH11-02-0124

[Summary] [Free PDF] [Export citation]
3.

See also Editorial by Ohman, Roe and Wallentin et al.

V. L. Serebruany (1)

(1) HeartDrug™ Research Laboratories, Johns Hopkins University, Towson, Maryland, USA

Thromb Haemost 2011 105 5: 752-759

https://doi.org/10.1160/TH10-12-0807

[Summary] [Free PDF] [Export citation]
4.
The PLATO trial reveals further opportunities to improve outcomes in patients with acute coronary syndrome
Editorial on Serebruany. "Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified" (Thromb Haemost 2011; 105.5)

Editorial on Serebruany

L. Wallentin (1), R. C. Becker (2), S. K. James (1), R. A. Harrington (2)

(1) Uppsala Clinical Research Centre, Uppsala, Sweden; (2) Duke Clinical Research Institute, Durham, North Carolina, USA

Thromb Haemost 2011 105 5: 760-762

https://doi.org/10.1160/TH11-03-0162

[Summary] [Free PDF] [Export citation]
5.
Explaining the unexpected: Insights from the PLATelet inhibition and clinical Outcomes (PLATO) trial comparing ticagrelor and clopidogrel
Editorial on Serebruany "Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified" (Thromb Haemost 2011; 105.5)

Editorial on Serebruany

E. M. Ohman (1), M. T. Roe (1)

(1) Duke Clinical Research Institute and Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA

Thromb Haemost 2011 105 5: 763-765

https://doi.org/10.1160/TH11-03-0159

[Summary] [Free PDF] [Export citation]
6.

K. R. Bainey (1), T. F. Lai (1), S. R. Mehta (1)

(1) Department of Medicine, McMaster University and Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada

Thromb Haemost 2011 105 5: 766-773

https://doi.org/10.1160/TH10-10-0633

[Summary] [Free PDF] [Export citation]
7.

Video

R. T. A. Megens (1), O. Soehnlein (1)

(1) Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, Germany

Thromb Haemost 2011 105 5: 774-775

https://doi.org/10.1160/TH11-03-0181

[Summary] [Free PDF] [Export citation]
8.

L. Bellido-Martín (1), V. Chen (1), R. Jasuja (1), B. Furie (2), B. C. Furie (2)

(1) Division of Hemostasis and Thrombosis, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachussetts, USA; (2) Harvard Medical School, Boston, Massachussetts, USA

Thromb Haemost 2011 105 5: 776-782

https://doi.org/10.1160/TH10-12-0771

[Summary] [Free PDF] [Export citation]
9.

E. Kenne (1), L. Lindbom (1)

(1) Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden

Thromb Haemost 2011 105 5: 783-789

https://doi.org/10.1160/TH10-10-0635

[Summary] [Free PDF] [Export citation]
10.

A. Constantinescu (1), J. A. E. Spaan (1), E. K. Arkenbout (2), H. Vink (3, 4), J. W. G. E. vanTeeffelen (4)

(1) Department of Medical Physics, Academic Medical Center, Amsterdam, the Netherlands; (2) Department of Medical Biochemistry, Academic Medical Center, Amsterdam, the Netherlands; (3) Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands; (4) Department of Physiology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands

Thromb Haemost 2011 105 5: 790-801

https://doi.org/10.1160/TH10-08-0560

[Summary] [Free PDF] [Export citation]
11.

R. T. A. Megens (1, 2, 3), K. Kemmerich (1, 3), J. Pyta (1), C. Weber (1, 3, 4), O. Soehnlein (1, 3, 4)

(1) Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Germany; (2) Interdisciplinary Center for Clinical Research (IZKF), RWTH Aachen University, Germany; (3) Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, Germany; (4) Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands

Thromb Haemost 2011 105 5: 802-810

https://doi.org/10.1160/TH10-11-0735

[Summary] [Free PDF] [Export citation]
12.

Online Supplementary Material

C. Gray (1, 2), C. A. Loynes (1, 3), M. K. B. Whyte (1, 3), D. C. Crossman (1, 2, 4), S. A. Renshaw (1, 3), T. J. A. Chico (1, 2, 4)

(1) MRC Centre for Developmental and Biomedical Genetics, University of Sheffield, Sheffield, UK; (2) Department of Cardiovascular Science, University of Sheffield, Sheffield, UK; (3) Department of Infection and Immunity, University of Sheffield, Sheffield, UK; (4) NIHR Cardiovascular Biomedical Research Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK

Thromb Haemost 2011 105 5: 811-819

https://doi.org/10.1160/TH10-08-0525

[Summary] [Free PDF] [Export citation]
13.

L. Zagorchev (1, 2, 3), M. J. Mulligan-Kehoe (4)

(1) Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire, USA; (2) Dartmouth Medical School, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA; (3) Philips Research North America, Briarcliff, New York, USA; (4) Department of Surgery, Vascular Section, Dartmouth Medical School, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA

Thromb Haemost 2011 105 5: 820-827

https://doi.org/10.1160/TH10-08-0562

[Summary] [Free PDF] [Export citation]
14.

T. Quillard (1), K. Croce (1), F. A. Jaffer (2), R. Weissleder (3), P. Libby (1)

(1) Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; (2) Cardiovascular Research Center, Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; (3) Center for Systems Biology and Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

Thromb Haemost 2011 105 5: 828-836

https://doi.org/10.1160/TH10-09-0589

[Summary] [Free PDF] [Export citation]
15.

B. Cosmi (1), C. Legnani (1), M. Cini (1), G. Guazzaloca (1), G. Palareti (1)

(1) Division of Angiology and Blood Coagulation “M. Golinelli”; S. Orsola-Malpighi University Hospital, Bologna, Italy

Thromb Haemost 2011 105 5: 837-845

https://doi.org/10.1160/TH10-08-0559

[Summary] [PDF] [Pay per view] [Export citation]
16.

Q. Gao (1, 2), Y. Xiang (1, 3), Z. Chen (1, 3), L. Zeng (1, 3), X. Ma (1, 3), Y. Zhang (1)

(1) Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China; (2) School of Life Science, University of Science and Technology of China, Hefei, China; (3) Graduate School of Chinese Academy of Sciences, Beijing, China

Thromb Haemost 2011 105 5: 846-854

https://doi.org/10.1160/TH10-10-0690

[Summary] [PDF] [Pay per view] [Export citation]
17.

L. Navarro-Núñez (1), R. Teruel (1), A. I. Antón (1), P. Nurden (2), I. Martínez-Martínez (1), M. L. Lozano (1), J. Rivera (1), J. Corral (1), D. Mezzano (3), V. Vicente (1), C. Martinez (1)

(1) Centro Regional de Hemodonación, University of Murcia, Spain; (2) Centre de Référence des Pathologies Plaquettaires, Plateforme Technologique et d'Innovation Biomédicale, Hôpital Cardiologique, Pessac, France; (3) Pontificia Universidad Católica de Chile, Santiago, Chile

Thromb Haemost 2011 105 5: 855-863

https://doi.org/10.1160/TH10-08-0536

[Summary] [PDF] [Pay per view] [Export citation]
18.

M. Joner (1), R. A. Byrne (1), J.-M. Lapointe (2), P. W. Radke (3), G. Bayer (4), K. Steigerwald (1), E. Wittchow (4)

(1) Deutsches Herzzentrum München, Munich, Germany; (2) AccelLAB Inc, Boisbriand, Quebec, Canada; (3) Universitätsklinik Schleswig- Holstein, Campus Lübeck, Lübeck, Germany; (4) Biotronik SE & Co.KG, Berlin-Neukölln, Germany

Thromb Haemost 2011 105 5: 864-872

https://doi.org/10.1160/TH10-11-0698

[Summary] [PDF] [Pay per view] [Export citation]
19.

Online Supplementary Material

B. Hurtado (1, 2), X. Muñoz (1), P. Recarte-Pelz (2), N. García (1), A. Luque (3), J. Krupinski (3, 4, 5, 6), N. Sala (1), P. García de Frutos (2)

(1) Translational Research Laboratory, Catalan Institute of Oncology-IDIBELL, L’Hospitalet de Llobregat, Spain; (2) Department of Cell Death and Proliferation, IIBB-CSIC-IDIBAPS, Barcelona, Spain; (3) Cardiovascular Research Center, ICCC, Barcelona, Spain; (4) Department of Neurology, Stroke Unit, Hospital Universitari Mutua de Terrassa, Terrassa, Spain; (5) Fundacio IDIBELL, Barcelona, Spain; (6) School of Biology, Chemistry and Health Science, and Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK

Thromb Haemost 2011 105 5: 873-882

https://doi.org/10.1160/TH10-10-0630

[Summary] [PDF] [Pay per view] [Export citation]
20.

K. M. Katsaros (1, 2), F. Wiesbauer (1), W. S. Speidl (1), S. P. Kastl (1, 2), K. Huber (3), G. Zorn (1), A. Niessner (1), D. Glogar (1), G. Maurer (1), J. Wojta (1, 2)

(1) Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria; (2) Ludwig Boltzmann Cluster for Cardiovascular Research; (3) 3rd Department of Medicine, Wilhelminenhospital, Vienna, Austria

Thromb Haemost 2011 105 5: 883-891

https://doi.org/10.1160/TH10-09-0566

[Summary] [PDF] [Pay per view] [Export citation]
  1-20 21-28